Azaindole derivatives as CRTH2 receptor antagonists
US8546422B2 · kind B2 · utility
5Cited by
2References
27Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 17, 2009 |
| Grant date | Oct 1, 2013 |
| Priority date | — |
| Expiry date | Jul 31, 2030 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compounds of formula I are antagonists of the PGD2 receptor, CRTH2, and as such are useful in the treatment and/or prevention of CRTH2-mediated diseases such as asthma.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.